3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
2
Unknown
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
64
Colorectal Neoplasms
58
Rectal Neoplasms
46
Stomach Neoplasms
44
Neoplasm Metastasis
16
Pancreatic Neoplasms
15
Colonic Neoplasms
13
Triple Negative Breast Neoplasms
11
Neoplasms
11
Esophageal Neoplasms
9
Nasopharyngeal Carcinoma
8
Locally Advanced Rectal Cancer
7
Esophageal Squamous Cell Carcinoma
7
Cholangiocarcinoma
6
Biliary Tract Neoplasms
6
Carcinoma, Hepatocellular
5
HER2 Positive Metastatic Breast Cancer
4
Colorectal Cancer Metastatic
4
Adenocarcinoma
4
Solid Tumor
3
Recurrence
3
Gallbladder Neoplasms
3
Anus Neoplasms
3
Advanced Breast Cancer
3
Squamous Cell Carcinoma of Head and Neck
2
Solid Tumors
2
Neuroendocrine Tumors
2
Locally Advanced Colon Cancer
2
Hyperthermia
2
Head and Neck Neoplasms
2
Interventions
Folfox protocol
2
Drug Therapy
2
camrelizumab
1
apatinib
1
aldesleukin
1
XELOX
1
Trastuzumab
1
Radiotherapy
1
Oxaliplatin
1
Intermittent Pneumatic Compression Devices
1
Endoscopy
1
Chemoradiotherapy
1
Cathartics
1
Capecitabine
1
Bevacizumab
1
Aspirin
1
Artesunate
1
Anti-Bacterial Agents
1
(2-(1R)-1-cyclopropyl)ethyl-6-isopropyl-phenol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Intestinal Neoplasms
×
Capecitabine
×
Clear all
NCT03280407
2017-09-28
NEOLAR
Zealand University Hospital
Phase 2
Unknown
124 enrolled